Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.01 | -0.689655172414 | 1.45 | 1.51 | 1.41 | 65141 | 1.44341399 | CS |
| 4 | -0.15 | -9.43396226415 | 1.59 | 1.65 | 1.385 | 137732 | 1.48281695 | CS |
| 12 | 0.2799 | 24.1272304112 | 1.1601 | 1.68 | 1.07 | 228851 | 1.47931313 | CS |
| 26 | 0.37 | 34.5794392523 | 1.07 | 1.68 | 0.9612 | 175186 | 1.36534826 | CS |
| 52 | 0.29 | 25.2173913043 | 1.15 | 1.68 | 0.9612 | 167277 | 1.26613379 | CS |
| 156 | -58.53 | -97.5987993997 | 59.97 | 59.97 | 0.9612 | 92997 | 2.85101051 | CS |
| 260 | -58.53 | -97.5987993997 | 59.97 | 59.97 | 0.9612 | 55665 | 2.85101051 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
